Baldelli R - Search Results

1

Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes.

Bianchi A, Valentini F, Iuorio R, Poggi M, Baldelli R, Passeri M, Giampietro A, Tartaglione L, Chiloiro S, Appetecchia M, Gargiulo P, Fabbri A, Toscano V, Pontecorvi A, De Marinis L. Bianchi A, et al. Among authors: baldelli r. J Exp Clin Cancer Res. 2013 Jun 21;32(1):40. doi: 10.1186/1756-9966-32-40. J Exp Clin Cancer Res. 2013. PMID: 23799893 Free PMC article.

2

Cardiac effects of slow-release lanreotide, a slow-release somatostatin analog, in acromegalic patients.

Baldelli R, Ferretti E, Jaffrain-Rea ML, Iacobellis G, Minniti G, Caracciolo B, Moroni C, Cassone R, Gulino A, Tamburrano G. Baldelli R, et al. J Clin Endocrinol Metab. 1999 Feb;84(2):527-32. doi: 10.1210/jcem.84.2.5467. J Clin Endocrinol Metab. 1999. PMID: 10022411 Clinical Trial.

3

Comparison of six months therapy with octreotide versus lanreotide in acromegalic patients: a retrospective study.

Razzore P, Colao A, Baldelli R, Gaia D, Marzullo P, Ferretti E, Ferone D, Jaffrain-Rea ML, Tamburrano G, Lombardi G, Camanni F, Ciccarelli E. Razzore P, et al. Among authors: baldelli r. Clin Endocrinol (Oxf). 1999 Aug;51(2):159-64. doi: 10.1046/j.1365-2265.1999.00812.x. Clin Endocrinol (Oxf). 1999. PMID: 10468985

4

Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy.

Colao A, Baldelli R, Marzullo P, Ferretti E, Ferone D, Gargiulo P, Petretta M, Tamburrano G, Lombardi G, Liuzzi A. Colao A, et al. Among authors: baldelli r. J Clin Endocrinol Metab. 2000 Jan;85(1):193-9. doi: 10.1210/jcem.85.1.6318. J Clin Endocrinol Metab. 2000. PMID: 10634386 Clinical Trial.

5

Efficacy and safety of the new 60-mg formulation of the long-acting somatostatin analog lanreotide in the treatment of acromegaly.

Ambrosio MR, Franceschetti P, Bondanelli M, Doga M, Maffei P, Baldelli R, Tamburrano G, Sicolo N, Giustina A, degli Uberti EC. Ambrosio MR, et al. Among authors: baldelli r. Metabolism. 2002 Mar;51(3):387-93. doi: 10.1053/meta.2002.30526. Metabolism. 2002. PMID: 11887179 Clinical Trial.

6

Glucose homeostasis in acromegaly: effects of long-acting somatostatin analogues treatment.

Baldelli R, Battista C, Leonetti F, Ghiggi MR, Ribaudo MC, Paoloni A, D'Amico E, Ferretti E, Baratta R, Liuzzi A, Trischitta V, Tamburrano G. Baldelli R, et al. Clin Endocrinol (Oxf). 2003 Oct;59(4):492-9. doi: 10.1046/j.1365-2265.2003.01876.x. Clin Endocrinol (Oxf). 2003. PMID: 14510913

7

Lanreotide 60 mg, a new long-acting formulation: effectiveness in the chronic treatment of acromegaly.

Attanasio R, Baldelli R, Pivonello R, Grottoli S, Bocca L, Gasco V, Giusti M, Tamburrano G, Colao A, Cozzi R. Attanasio R, et al. Among authors: baldelli r. J Clin Endocrinol Metab. 2003 Nov;88(11):5258-65. doi: 10.1210/jc.2003-030266. J Clin Endocrinol Metab. 2003. PMID: 14602759 Clinical Trial.

8

Serum leptin levels in acromegalic patients before and during somatostatin analogs therapy.

Baldelli R, Durante C, D'Amico E, Diacono F, Tamburrano G, Casanueva FF. Baldelli R, et al. J Endocrinol Invest. 2003 Dec;26(12):1219-24. doi: 10.1007/BF03349161. J Endocrinol Invest. 2003. PMID: 15055476 Clinical Trial.

9

Characteristics of adult patients with growth hormone deficiency who underwent neurosurgery for functioning and non-functioning pituitary adenomas and craniopharyngiomas.

Baldelli R, Bianchi A, Diacono F, Passeri M, Fusco A, Valle D, Poggi M, Terlini M, Toscano V, Tamburrano G, Pontecorvi A, Maira G, De Marinis L. Baldelli R, et al. J Endocrinol Invest. 2005 Feb;28(2):157-61. doi: 10.1007/BF03345359. J Endocrinol Invest. 2005. PMID: 15887862

10

Hypopituitarism induced by traumatic brain injury in the transition phase.

Aimaretti G, Ambrosio MR, Di Somma C, Gasperi M, Cannavò S, Scaroni C, De Marinis L, Baldelli R, Bona G, Giordano G, Ghigo E. Aimaretti G, et al. Among authors: baldelli r. J Endocrinol Invest. 2005 Dec;28(11):984-9. doi: 10.1007/BF03345336. J Endocrinol Invest. 2005. PMID: 16483176

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters